JO
MED icon

John Overdeck’s Medifast MED Stock Holding History

John Overdeck’s Portfolio MED Stock Details MED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-6,500
Closed -$1.36M – 3663
2021
Q4 		$1.36M Sell
6,500
-2,800
-30% -$579K ﹤0.01% 2282
2021
Q3 		$1.79M Buy
9,300
+7,700
+481% +$1.89M ﹤0.01% 2092
2021
Q2 		$453K Sell
1,600
-1,400
-47% -$379K ﹤0.01% 3188
2021
Q1 		$635K Buy
3,000
+1,500
+100% +$359K ﹤0.01% 2701
2020
Q4 		$295K Sell
1,500
-4,100
-73% -$725K ﹤0.01% 2877
2020
Q3 		$921K Buy
+5,600
New +$922K ﹤0.01% 1820
2020
Q2 		– Sell
-9,100
Closed -$569K – 3292
2020
Q1 		$569K Buy
9,100
+6,800
+296% +$619K ﹤0.01% 1830
2019
Q4 		$252K Sell
2,300
-6,100
-73% -$590K ﹤0.01% 3302
2019
Q3 		$870K Buy
8,400
+4,900
+140% +$527K ﹤0.01% 2098
2019
Q2 		$449K Buy
3,500
+1,500
+75% +$208K ﹤0.01% 2585
2019
Q1 		$255K Buy
+2,000
New +$254K ﹤0.01% 2699
2018
Q4 		– Sell
-2,000
Closed -$443K – 3318
2018
Q3 		$443K Buy
+2,000
New +$405K ﹤0.01% 2542

Other funds holding MED

Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
SCP
Steamboat Capital Partners Rye, New York $468M AUM 80.81% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

John Overdeck's MED Position: Q2 2026 in Review

John Overdeck increased its Medifast (MED) stake by 42% in Q2 2026, buying an estimated $1.65M and bringing the position to 481,381 shares worth $5.11M. The position accounts for ﹤0.01% of the portfolio, ranked #2124.

John Overdeck first reported a position in MED in Q3 2013 and has held it in 29 quarters since. The position peaked at $31.6M in Q3 2020. 112 funds tracked by Wall St. Rank hold MED as of Q2 2026.

  • John Overdeck held 481,381 shares of Medifast worth $5.11M as of Q2 2026.
  • John Overdeck bought 143,223 Medifast shares in Q2 2026, an estimated $1.65M.
  • Medifast made up ﹤0.01% of John Overdeck's portfolio in Q2 2026, its #2124 holding.
  • John Overdeck first reported a position in Medifast in Q3 2013 and has held it in 29 quarters since.
  • John Overdeck's Medifast position peaked at $31.6M in Q3 2020.
  • 112 funds tracked by Wall St. Rank held Medifast as of Q2 2026.

Based on Two Sigma Investments's 13F filing for Q2 2026, filed 14 Aug 2026.